These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 20596295

  • 41. The Atxn7-overexpressing mice showed hyperactivity and impulsivity which were ameliorated by atomoxetine treatment: A possible animal model of the hyperactive-impulsive phenotype of ADHD.
    Dela Peña IJI, Botanas CJ, de la Peña JB, Custodio RJ, Dela Peña I, Ryoo ZY, Kim BN, Ryu JH, Kim HJ, Cheong JH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan 10; 88():311-319. PubMed ID: 30125623
    [Abstract] [Full Text] [Related]

  • 42. Dopamine vs noradrenaline: inverted-U effects and ADHD theories.
    Levy F.
    Aust N Z J Psychiatry; 2009 Feb 10; 43(2):101-8. PubMed ID: 19153917
    [Abstract] [Full Text] [Related]

  • 43. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T.
    Behav Brain Funct; 2006 Dec 15; 2():41. PubMed ID: 17173664
    [Abstract] [Full Text] [Related]

  • 44. Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders.
    Gamo NJ, Arnsten AF.
    Behav Neurosci; 2011 Jun 15; 125(3):282-96. PubMed ID: 21480691
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation.
    Mortimer N, Ganster T, O'Leary A, Popp S, Freudenberg F, Reif A, Soler Artigas M, Ribasés M, Ramos-Quiroga JA, Lesch KP, Rivero O.
    Neuropharmacology; 2019 Sep 15; 156():107557. PubMed ID: 30849401
    [Abstract] [Full Text] [Related]

  • 48. Changes in the second messenger cyclic AMP during development may underlie motoric symptoms in attention deficit/hyperactivity disorder (ADHD).
    Andersen SL.
    Behav Brain Res; 2002 Mar 10; 130(1-2):197-201. PubMed ID: 11864735
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Interaction between DRD2 and lead exposure on the cortical thickness of the frontal lobe in youth with attention-deficit/hyperactivity disorder.
    Kim JI, Kim JW, Lee JM, Yun HJ, Sohn CH, Shin MS, Kim B, Chae J, Roh J, Kim BN.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar 02; 82():169-176. PubMed ID: 29169998
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Impaired reward processing in the human prefrontal cortex distinguishes between persistent and remittent attention deficit hyperactivity disorder.
    Wetterling F, McCarthy H, Tozzi L, Skokauskas N, O'Doherty JP, Mulligan A, Meaney J, Fagan AJ, Gill M, Frodl T.
    Hum Brain Mapp; 2015 Nov 02; 36(11):4648-63. PubMed ID: 26287509
    [Abstract] [Full Text] [Related]

  • 57. Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness.
    Arnsten AF.
    Cereb Cortex; 2007 Sep 02; 17 Suppl 1():i6-15. PubMed ID: 17434919
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Altered resting-state frontoparietal control network in children with attention-deficit/hyperactivity disorder.
    Lin HY, Tseng WY, Lai MC, Matsuo K, Gau SS.
    J Int Neuropsychol Soc; 2015 Apr 02; 21(4):271-84. PubMed ID: 25928822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.